Ibuprofen Lysine

DRUG3 trials

Sponsors

Reckitt Benckiser Healthcare (UK) Limited, Oxford Pharmascience Ltd

Conditions

Healthy SubjectsHealthy Volunteer StudyPharmacokinetics

Phase 1

Ibuprofen and Paracetamol Pharmacokinetic Study

CompletedNCT02452450

Reckitt Benckiser Healthcare (UK) LimitedHealthy Volunteer Study

Start: 2014-01-31End: 2014-10-31Updated: 2015-05-27

Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen

CompletedNCT02974361

Oxford Pharmascience LtdPharmacokinetics

Start: 2016-12-31End: 2017-05-03Updated: 2017-05-03

Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.

TerminatedNCT03497715

Reckitt Benckiser Healthcare (UK) LimitedHealthy Subjects

Start: 2015-04-14End: 2015-07-30Updated: 2018-04-13

Related Papers

Predicting rapid analgesic onset of ibuprofen salts compared with ibuprofen acid: T<sub>lag</sub>, T<sub>low</sub>, T<sub>med</sub>, and a novel parameter, T<sub>C</sub><sub>maxRef</sub>.

2018-04-273 citations